Integral Diagnostics Limited
ITGDF
$2.06
$0.687450.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.73M | -17.90M | -39.62M | -38.64M | -37.59M |
| Total Depreciation and Amortization | 31.36M | 31.14M | 30.73M | 30.21M | 29.87M |
| Total Amortization of Deferred Charges | 288.30K | 288.30K | 288.30K | 274.60K | 264.20K |
| Total Other Non-Cash Items | 10.21M | 29.78M | 49.46M | 43.81M | 38.17M |
| Change in Net Operating Assets | 2.62M | 2.62M | 2.62M | 5.30M | 8.07M |
| Cash from Operations | 48.19M | 45.92M | 43.48M | 40.95M | 38.78M |
| Capital Expenditure | -25.72M | -20.81M | -15.66M | -21.82M | -28.23M |
| Sale of Property, Plant, and Equipment | 206.90K | 104.90K | -- | -- | -- |
| Cash Acquisitions | 9.71M | 3.61M | -2.63M | -2.68M | -2.73M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.53M | -6.86M | -- | 16.70K | 33.80K |
| Cash from Investing | -29.34M | -23.95M | -18.29M | -24.49M | -30.93M |
| Total Debt Issued | 323.38M | 161.69M | -- | 21.52M | 43.05M |
| Total Debt Repaid | -325.14M | -171.25M | -17.35M | -38.60M | -59.85M |
| Issuance of Common Stock | 1.52M | 1.66M | 1.81M | 1.49M | 1.17M |
| Repurchase of Common Stock | -87.00K | -87.00K | -87.00K | -43.50K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -9.12M | -9.12M | -9.06M | -9.00M | -9.00M |
| Other Financing Activities | -719.00K | -359.50K | 0.00 | -43.50K | -87.00K |
| Cash from Financing | -9.79M | -14.54M | -19.31M | -19.32M | -19.44M |
| Foreign Exchange rate Adjustments | -343.90K | -245.20K | -145.40K | -77.20K | -11.10K |
| Miscellaneous Cash Flow Adjustments | -600.00 | -300.00 | 0.00 | -43.80K | -88.60K |
| Net Change in Cash | 8.71M | 7.18M | 5.73M | -2.98M | -11.68M |